• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    REPAY Appoints New Chief Financial Officer

    8/11/25 4:06:00 PM ET
    $CNDT
    $FI
    $IART
    $MRK
    Real Estate
    Real Estate
    Real Estate
    Real Estate
    Get the next $CNDT alert in real time by email

    Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today announced the appointment of Robert Houser as Chief Financial Officer of the Company, effective September 8, 2025.

    "We are extremely excited to welcome Rob to REPAY. Rob brings over a decade of divisional CFO and operational experience within the payment industry to help him contribute immediately. Rob has held key strategic roles across his career and will be a great partner in running our company," said John Morris, Co-Founder and CEO.

    Most recently, Rob served as the Group CFO of the Public Sector and Advisor at Conduent Incorporated (NASDAQ:CNDT) ("Conduent"). He previously served as Conduent's Global Head of Strategy, Corporate Development and Advisor to CEO. Prior to Conduent, Rob spent seven years at Fiserv, Inc. (NYSE:FI) holding positions as Senior Vice President, General Manager, and CFO across several divisions. Prior to Fiserv, he was the Global Head of FP&A and Investor Relations at Integra Lifesciences, Inc. (NASDAQ:IART). He previously held various finance, accounting, and strategy roles at Firmenich, Inc, Bristol-Myers Squibb Co. (NYSE:NMY), and Merck & Co Inc. (NYSE:MRK). Rob began his career as an auditor for KPMG LLP, and he earned his MBA and bachelor's degree in accounting from Rider University.

    "With Rob's appointment, interim CFO Thomas Sullivan will return to his role as Chief Accounting Officer. We are extremely grateful for Thomas's help in managing the finance organization over the past several months and the entire REPAY team for supporting the company through the CFO transition," said John Morris.

    About REPAY

    REPAY provides integrated payment processing solutions to verticals that have specific transaction processing needs. REPAY's proprietary, integrated payment technology platform reduces the complexity of electronic payments for clients, while enhancing the overall experience for consumers and businesses.

    Forward-Looking Statements

    This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about REPAY's expectations with respect to the announced leadership changes. Such forward-looking statements are based upon the current beliefs and expectations of REPAY's management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond REPAY's control, including, without limitation, the factors described in REPAY's reports filed with the U.S. Securities and Exchange Commission. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. All information set forth herein speaks only as of the date hereof in the case of information about REPAY or the date of such information in the case of information.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250811411111/en/

    Investor Relations for REPAY:

    ir@repay.com



    Media Relations for REPAY:

    Kristen Hoyman

    khoyman@repay.com

    Get the next $CNDT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNDT
    $FI
    $IART
    $MRK

    CompanyDatePrice TargetRatingAnalyst
    Integra LifeSciences Holdings Corporation
    $IART
    5/28/2026$16.00Sell → Neutral
    Citigroup
    Merck & Company Inc.
    $MRK
    5/6/2026$125.00Neutral
    Citigroup
    Repay Holdings Corporation
    $RPAY
    5/5/2026$3.75Overweight → Equal-Weight
    Stephens
    Integra LifeSciences Holdings Corporation
    $IART
    4/15/2026Buy → Hold
    Argus
    Merck & Company Inc.
    $MRK
    2/25/2026$142.00Outperform
    RBC Capital Mkts
    Merck & Company Inc.
    $MRK
    2/20/2026$140.00Overweight
    Barclays
    Merck & Company Inc.
    $MRK
    2/13/2026$150.00Hold → Buy
    Deutsche Bank
    Merck & Company Inc.
    $MRK
    1/8/2026$135.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $CNDT
    $FI
    $IART
    $MRK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    REPAY Announces Inducement Award Grant for Rick Watkin

    Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of vertically-integrated payment solutions, today announced an inducement award grant to Rick Watkin in connection with the closing of REPAY's acquisition of KUBRA Data Transfer, Ltd. ("KUBRA"). Mr. Watkin will serve as President, KUBRA. REPAY agreed to grant Mr. Watkin 833,333 restricted stock units ("RSUs") as a material inducement to his entering into employment with the Company effective upon the closing of the KUBRA acquisition. The award was approved by the Compensation Committee (the "Compensation Committee") of REPAY's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4). The gr

    6/3/26 4:25:00 PM ET
    $RPAY
    Real Estate

    Forager Capital Intends to Vote Against All Director Nominees at Repay's June 10, 2026 Annual Meeting

    BIRMINGHAM, Ala., June 03, 2026 (GLOBE NEWSWIRE) -- Forager Capital Management ("Forager"), the largest stockholder of Repay Holdings Corporation (NASDAQ:RPAY), with beneficial ownership of approximately 13% of the issued and outstanding shares, issued the following statement: "A Board presented with a 75% premium all-cash proposal should substantively engage. Not necessarily agree with it. Not accept it. But engage. Instead, Paul Garcia, Maryann Goebel, Pete Kight, Emnet Rios, and Richard Thornburgh refused substantive engagement and repeatedly chose governance paths that left stockholders with no meaningful voice and the Board with more control. That pattern is problematic under any c

    6/3/26 3:22:50 PM ET
    $RPAY
    Real Estate

    Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity

    WESTON, Fla., June 3, 2026 /CNW/ - Apotex Corp. ("Apotex") today announced the U.S. launch of sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, both of which are eligible for 180‑day shared exclusivity. These launches expand Apotex's portfolio of treatment options for adults living with type 2 diabetes mellitus.  Type 2 diabetes affects millions of adults in the United States, and treatment often requires long-term, reliable access to prescribed therapies. Sitagliptin tablets are AB rated (per FDA's Approved Drug Products with Therapeutic Equivalence Evaluations) to JANUVIA® (Merck) and are indicated as a

    6/3/26 9:00:00 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CNDT
    $FI
    $IART
    $MRK
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Repay Holdings Corporation

    SCHEDULE 13D/A - Repay Holdings Corp (0001720592) (Subject)

    6/3/26 3:59:12 PM ET
    $RPAY
    Real Estate

    Repay Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation, Regulation FD Disclosure

    8-K - Repay Holdings Corp (0001720592) (Filer)

    6/1/26 4:14:04 PM ET
    $RPAY
    Real Estate

    SEC Form SD filed by Integra LifeSciences Holdings Corporation

    SD - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)

    5/29/26 4:42:09 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CNDT
    $FI
    $IART
    $MRK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Integra upgraded by Citigroup with a new price target

    Citigroup upgraded Integra from Sell to Neutral and set a new price target of $16.00

    5/28/26 8:44:41 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Merck with a new price target

    Citigroup resumed coverage of Merck with a rating of Neutral and set a new price target of $125.00

    5/6/26 7:35:08 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Repay Holdings downgraded by Stephens with a new price target

    Stephens downgraded Repay Holdings from Overweight to Equal-Weight and set a new price target of $3.75

    5/5/26 7:44:12 AM ET
    $RPAY
    Real Estate

    $CNDT
    $FI
    $IART
    $MRK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Agadi Harshavardhan V bought $182,909 worth of shares (117,099 units at $1.56) (SEC Form 4)

    4 - CONDUENT Inc (0001677703) (Issuer)

    2/23/26 5:21:51 PM ET
    $CNDT
    Real Estate

    Chief Executive Officer Agadi Harshavardhan V bought $313,720 worth of shares (220,000 units at $1.43) (SEC Form 4)

    4 - CONDUENT Inc (0001677703) (Issuer)

    2/20/26 11:36:25 AM ET
    $CNDT
    Real Estate

    Director Palau Hernandez Margarita bought $72,650 worth of shares (50,000 units at $1.45) (SEC Form 4)

    4 - CONDUENT Inc (0001677703) (Issuer)

    2/20/26 11:33:12 AM ET
    $CNDT
    Real Estate

    $CNDT
    $FI
    $IART
    $MRK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, KUBRA Watkin Richard Jason was granted 833,333 shares, increasing direct ownership by 833,333% to 833,433 units (SEC Form 4)

    4 - Repay Holdings Corp (0001720592) (Issuer)

    6/3/26 5:00:19 PM ET
    $RPAY
    Real Estate

    SEC Form 4 filed by EVP & Chief Commercial Officer Mcbreen Michael J.

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    6/3/26 4:58:41 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by President and CEO Essig Stuart

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    6/3/26 4:54:58 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CNDT
    $FI
    $IART
    $MRK
    Financials

    Live finance-specific insights

    View All

    REPAY Completes Acquisition of KUBRA

    REPAY Becomes a Leading Consumer Bill Payment Provider Announces Investor Day for December 2026 Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today announced that it has completed the acquisition of Kubra Data Transfer LTD. ("KUBRA"). Under the terms of the agreement, REPAY acquired KUBRA for $372 million in cash. REPAY announced the definitive agreement to acquire KUBRA on March 30, 2026. "With the addition of KUBRA, REPAY expands our position as a leading Consumer Bill Payment Provider with the technology and market position to lead the digital journey across the payment ecosystem," said John Morri

    6/1/26 4:09:00 PM ET
    $RPAY
    Real Estate

    Merck Announces Third-Quarter 2026 Dividend

    Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company's common stock for the third quarter of 2026. Payment will be made on July 8, 2026, to shareholders of record at the close of business on June 15, 2026. About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intens

    5/26/26 1:28:00 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Conduent Reports Significantly Improved First Quarter 2026 Financial Results

    Key Q1 2026 Highlights Revenue: $723M, down 3.7%. Growth in Government and Transportation segmentsPre-tax Income (Loss): $(27)M, improved by $29M year-over-yearAdj. EBITDA(1): $49M, improved by $12M year-over-yearAdj. EBITDA Margin(1): 6.8%, improved by 190 bps year-over-yearCash flow from operating activities: $(8)M, improved by $50M year-over-yearNew Business Signings ACV(2): $114M, improved by $5M year-over-year FLORHAM PARK, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Conduent Incorporated (NASDAQ:CNDT), a global technology driven business process solutions and services company, today announced its first quarter 2026 financial results. Harsha V. Agadi, Chief Executive Officer, stated, "Q

    5/11/26 4:01:00 PM ET
    $CNDT
    Real Estate

    $CNDT
    $FI
    $IART
    $MRK
    Leadership Updates

    Live Leadership Updates

    View All

    Conduent Appoints Adam Demuyakor to Board of Directors

    Technology Investor and Digital Transformation Leader Brings Deep Expertise in AI, Innovation and Enterprise Technology Strategy Conduent Incorporated (NASDAQ:CNDT), a global technology-driven business solutions and services company, today announced the appointment of Adam Demuyakor to its Board of Directors, effective June 1, 2026. Mr. Demuyakor brings experience in technology, strategic investing, and business transformation, with a track record of advising organizations on innovation, enterprise modernization, and growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520619952/en/Adam Demuyakor Mr. Demuyakor is Founder

    5/20/26 4:15:00 PM ET
    $CNDT
    Real Estate

    Merck's Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called "Bad" Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

    The Yankees, Red Sox, Phillies, Braves, Astros, Cardinals, Giants, Padres, and Angels are joining Merck to help educate fans about high bad cholesterol and how it may increase the risk of heart attack or stroke Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced a collaboration with nine professional baseball teams and former professional baseball players to launch the Playing with Heart educational program to help educate adults about the importance of knowing their low-density lipoprotein cholesterol (LDL-C), called "bad" cholesterol, number and the potential increased risk of heart attack or stroke. Playing with Heart connects Merck's commitment to

    4/28/26 6:45:00 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    REPAY Announces New Consumer Payments Leader

    Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today announced the appointment of Matt Morrow as the new executive leader of Consumer Payments, effective May 12, 2026. Matt will lead REPAY's Consumer Payments overall strategy, overseeing the segment's growth, sales, and operational initiatives across REPAY's consumer finance verticals, including personal lending, automative loans, accounts receivable management, healthcare and mortgage servicing. In his new role, Matt will report to John Morris, REPAY's CEO. Matt brings over a decade of payments and business services experience managing divisional busines

    4/16/26 4:05:00 PM ET
    $RPAY
    Real Estate

    $CNDT
    $FI
    $IART
    $MRK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Repay Holdings Corporation

    SC 13G - Repay Holdings Corp (0001720592) (Subject)

    11/14/24 5:17:53 PM ET
    $RPAY
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Conduent Incorporated

    SC 13G/A - CONDUENT Inc (0001677703) (Subject)

    11/14/24 1:28:32 PM ET
    $CNDT
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Fiserv Inc.

    SC 13G/A - FISERV INC (0000798354) (Subject)

    11/14/24 1:22:34 PM ET
    $FI
    Real Estate